- Posted on 4 Oct 2022
- 1-minute read
Features include:
- Using choice to understand preferences to undertake polygenic risk scores tests to estimate cancer risk (CHERE)
- Australasian Gastro-Intestinal Trials Group (AGITG)
- Australia New Zealand Gynaecological Oncology Group (ANZGOG)
- Australia and New Zealand Sarcoma Association (ANZSA)
-
Cancer Quality of Life Expert Service Team (CQUEST)
- Upcoming Workshop: Choosing patient reported outcome measures (PROM) for cancer clinical research, 12th October @5pm (Zoom)
- An Australia first: Best-practice bundle for private breast cancer treatment (Paying for Value)
-
Australian & New Zealand Urogenital and Prostate (ANZUP)
- Upcoming workshops: Best of GU Oncology Evening Symposium, 9th November (Melbourne); and Prostate Cancer Rapid Fire Program, 18-19 November (Sydney)
- Breast Cancer Trials (BCT)
- Cancer Symptom Trials (CST)
- Melanoma and Skin Cancer trials (MASC)
- Psycho-oncology Co-operative Research Group (PoCoG)
- Quality of life in survivors of breast cancer once, three and five years post-diagnosis
- Australasian Leukaemia & Lymphoma Group (ALLG)
- Trans Tasman Radiation Oncology Group (TROG)
-
CREST Health Economics Workshop
Health Technology Assessment Webinar Series
Understanding health economics in Cancer Research, 18th November (Zoom)
- CREST Monthly Drop-In Health Economics Clinics